Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 2
1997 2
1998 2
1999 7
2000 4
2001 3
2002 5
2003 2
2004 2
2005 5
2006 3
2007 5
2008 5
2009 9
2010 3
2011 10
2012 7
2013 12
2014 15
2015 15
2016 13
2017 11
2018 11
2019 8
2020 8
2021 8
2022 8
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of upper and lower airway expression of SARS-COV-2 receptors in allergic asthma.
Ranjbar M, Whetstone CE, Cusack RP, Al-Sajee D, Omer H, Alsaji N, Ho T, Duong M, Mitchell P, Satia I, Keith PK, Xie Y, MacLean J, Sommer DD, O'Byrne PM, Sehmi R, Gauvreau GM. Ranjbar M, et al. Among authors: gauvreau gm. Allergy. 2024 May 10. doi: 10.1111/all.16157. Online ahead of print. Allergy. 2024. PMID: 38726474 No abstract available.
Biologic Therapy in Rare Eosinophil-Associated Disorders: Remaining Questions and Translational Research Opportunities.
Khoury P, Roufosse F, Kuang FL, Ackerman SJ, Akuthota P, Bochner BS, Johansson MW, Mathur SK, Ogbogu PU, Spencer LA, Wechsler ME, Zimmermann N, Klion AD; International Eosinophil Society Clinical Research Interest Group. Khoury P, et al. J Leukoc Biol. 2024 Mar 8:qiae051. doi: 10.1093/jleuko/qiae051. Online ahead of print. J Leukoc Biol. 2024. PMID: 38457125
Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.
Bauer RN, Xie Y, Beaudin S, Wiltshire L, Wattie J, Muñoz C, Alsaji N, Oliveria JP, Ju X, MacLean J, Sommer DD, Keith PK, Satia I, Cusack RP, O'Byrne PM, Sperinde G, Hokom M, Li O, Banerjee P, Chen C, Staton T, Sehmi R, Gauvreau GM. Bauer RN, et al. Among authors: gauvreau gm. Clin Exp Allergy. 2023 Nov;53(11):1187-1197. doi: 10.1111/cea.14406. Epub 2023 Oct 4. Clin Exp Allergy. 2023. PMID: 37794659
Refashioning dexpramipexole: A new horizon in eosinophilic asthma?
Cusack RP, Sulaiman I, Gauvreau GM. Cusack RP, et al. Among authors: gauvreau gm. J Allergy Clin Immunol. 2023 Nov;152(5):1092-1094. doi: 10.1016/j.jaci.2023.09.019. Epub 2023 Sep 26. J Allergy Clin Immunol. 2023. PMID: 37769877 No abstract available.
Anti-alarmin asthma therapies: where do we go from here?
Sulaiman I, Gauvreau GM. Sulaiman I, et al. Among authors: gauvreau gm. J Bras Pneumol. 2023 Jul 24;49(3):e20230220. doi: 10.36416/1806-3756/e20230220. J Bras Pneumol. 2023. PMID: 37493796 Free PMC article. No abstract available.
187 results